chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The doses are greater than 42 days apart; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The doses are greater than 42 days apart) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Sep-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The doses are greater than 42 days apart). On 07-Sep-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The doses are greater than 42 days apart) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 06-Oct-2021: Follow up document received contain no new information.
Large local reaction to IPV (L) thigh 9 cm of induration BENADRYL 25 mg qid prn apply ice prn.
Muscle aches, soreness, chills, jaw pain on right side similar to TMJ that has lasted more than 24 hours
Generalized hives following shingles vaccine. Lasted 1 week. Treated with BENADRYL for itchiness.
Received 2nd dose on 22nd day from 1st shot; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose on 22nd day from 1st shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported.).   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose on 22nd day from 1st shot). On 25-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose on 22nd day from 1st shot) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment related information has been reported.; Sender's Comments: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273 (Lot number: Not Provided) with no associated AEs.
This spontaneous report was received from a registered nurse, referring to multiple unspecified patients of unknown ages and genders. The patient's medical history or concurrent conditions were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of GARDASIL (which has the lot number of L009964, expiration date 13-APR-2017) (dose and route were not provided). There were no adverse effects reported. The vaccines experienced a temperature of 13.2 C in a time frame of 1 hour and 20 minutes, there had been no previous temperature excursion. Furthermore, no product quality complaint was involved. This is one of the several reports received from the same reporter. Additional information has been requested.
This is a spontaneous report received from contactable consumer or other non-HCP. A female patient received the 3rd (booster) dose of BNT162B2 (Comirnaty, batch/lot# unknown), single dose, for COVID-19 immunisation. Patient also takes Lenvima (lenvatinib mesilate) 12mg. The patient's medical history included liver cell carcinoma. Vaccination history included the 1st and 2nd dose of the COVID-19 vaccine (manufacturer unknown), for COVID-19 immunization. The patient reported immunization/booster, and malaise/not feeling great; both with outcome of unknown. No follow-up attempts possible. Information about lot/batch number cannot be obtained. No further information expected. Additional information: Prescribing HCP diagnosis on enrollment form is liver cell carcinoma for Lenvima 12mg. Sender's comments: Linked report(s): US-PFIZER INC-202101732726 same reporter/drug/event for different patients.
pt recv vax 9SEP96 & 10SEP96 exp an inj site rxn manifested by a raised circle (circumference=1inch) around the inj site w/fever & extreme soreness in arm;pt recovered;
Febrile seizures 6 days after having vaccines. Seen at hospital given MOTRIN in ER & urine checked, urine normal temp controlled with MOTRIN & TYLENOL.
2/19/21-swollen arm  2/20/21-fever, chills, shortness of breathe Patient stated she went to urgent care
Erythematous distal to injection site 3cm X 2cm, papules, excoriated, 1.5cm X 1 cm area where vaccine was administered.
I had some side effect from the booster of Pfizer; I have a kidney stone; blood in my urine; my left knee blew up like I have tons of fluid in it; my left knee blew up like I have tons of fluid in it; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose: 1, Primary Immunization series complete but unknown manufacturer. I didn't have any side effects with the two, the first two vaccine), for Covid-19 immunization, reaction(s): "No adverse effect"; Covid-19 vaccine (Dose: 2, Primary Immunization series complete but unknown manufacturer. I didn't have any side effects with the two, the first two vaccine), for Covid-19 immunization, reaction(s): "No adverse effect". The following information was reported: IMMUNISATION (medically significant), outcome "unknown", described as "I had some side effect from the booster of Pfizer"; NEPHROLITHIASIS (medically significant), outcome "unknown", described as "I have a kidney stone"; BLOOD URINE PRESENT (non-serious), outcome "unknown", described as "blood in my urine"; JOINT SWELLING (non-serious), JOINT EFFUSION (non-serious), outcome "unknown" and all described as "my left knee blew up like I have tons of fluid in it". The patient underwent the following laboratory tests and procedures: urine analysis: blood. It was reported that, patient three days of blood in urine after got the booster, within the couple of hours after the booster and also left knee blew up like I have tons of fluid in it. Patient did go to doctor and they said did have blood in urine but patient did not have an infection and patient went to neurologist because patient had a kidney stone (Further clarification unknown) and he said patient's kidney is look fine. Patient wanted to know if there is another people that have this problem, patient didn't have any side effects with the two, the first two vaccine, it was just the booster that caused this problem.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient developed ITP on 10/25/08 with a platelet count of 14,000.  12/2/08 Reviewed hospital medical records of 10/25-10/27/2008. FINAL DX: Idiopathic thrombocytopenic purpura Records reveal patient experienced extensive bruising & petechiae, marked auricular & inguinal lymphadenopathy x 1 day.  Tx w/IVIG
Terrible cold sweats; I sweat through my pajamas 4 times during the first night. I had terrible body aches everywhere, and brain fog. For instance - I couldn't find a blanket while I was freezing. I wandered all over the house looking for blankets, but they had fallen onto the floor right next to the bed. I might have had a fever but I was too 'out of it; to check. I ended up taking Tylenol at about 6am the next morning, which helped some. I'm still moving in slow motion and cancelled my doctor appointment today because my throat is sore now. I'm still feeling lethargic and have slight aches and pains. I didn't contact a doctor because I believe the worst part of my reaction is over.
I had a runny nose for a couple of days. I started to have shortness of breath and the cough started and would not stop. It got to a point where I was coughing the entire. I went home and took over the counter Robitussin.  About an hour later, it got really bad and I was unable to catch my breath. My son came and took me to the hospital. The gave me treatment and completed a  COVID-19 PCR  Test on September 01. I was given breathing treatments and sent home with an Albuterol inhaler and told me to contact my doctor. I took this over the weekend. On September 06, 2022, my doctor gave me Benzonatate which did nothing. The next day I went back into distress. I became really short of breath and the cough got worse and worse. My son checked my oxygen level which was between 86 to 91%. My son took me back to the emergency room. They completed a Cat Scan which showed 2 small pulmonary embolisms. I was admitted into the hospital and placed on blood thinners.  I spoke with a hematologist as well. I was sent home with pills for blood thinner and stay on the inhaler. I was given another cough medicine called Guaiatussin. The medications helped my symptoms. I was feeling a bit better over the weekend but woke up Tuesday and the symptoms were worse. I was having a hard time breathing, choking and coughing up a slime like mucus. I went back to the emergency room and was admitted. I was given some breathing treatments and had another  X-Ray-September 13, 2022. CT Scan-Pulmonary Embolism Resolved, I developed pneumonia and had sepsis due to pneumonia.  I had an episode where I could not breath and I was hooked up to a bypass machine and admitted to ICU. I was in the ICU for 4 days. I was diagnosed with acute and chronic respiratory failure with hypoxia and sepsis due to pneumonia. I was given tons of medications and advised to rest for a week and follow up with the specialist.
severe night sweats combined with small hive like rash on chest. rash site was itchy. sweating severe enough to soak through  head hair and sheets.  no fever detected when temperature  was taken at 6;30 am.   No other symptom noted.
The adverse event is related to the location the shot was administered. It was given very high on my left arm, almost the top of my shoulder. The nurse, was standing while I was seated. I realized he moved my sleeve up further on my shoulder, but I did not look when he did the injection. The band aid was place very high on my shoulder, higher than I have ever seen with previous vaccinations.  I felt more than the usual pain almost immediately and by the evening, my arm was throbbing and felt "frozen", where I could not move it independently. The pain was present from 10/10/23-10/16/23 where it subsided for approximately 2 days. On 10/19/23 the pain and inability to move my arm returned. I visited my orthopedic doctor (MD) on Monday 10/23/23 and was told it was Impingement syndrome resulting from improper vaccine administration causing bursitis and tendinitis. My shoulder was x-rayed and I was given a subacromial cortisone injection and told to return for follow-up on 12/6/23. On 11/2/23 my pain has not subsided, I contacted my doctor who prescribed DICLOFENAC SODIUM 50mg twice a day due to severe pain at night and in the morning. I am told to check in within a week if there is still no improvement to determine if an MRI is warranted.
This case was reported by a pharmacist via call center representative and described the occurrence of influenza-like symptoms in an unspecified number of adult patients who received SHINGRIX (batch number L9CS4, expiry date 22nd February 2021) for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced influenza-like symptoms, shivering and myalgia. On an unknown date, the outcome of the influenza-like symptoms, shivering and myalgia were unknown. It was unknown if the reporter considered the influenza-like symptoms, shivering and myalgia to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The healthcare professional reported that, a few patients have experienced flu-like symptoms such as shivering, chills and myalgia following the vaccination with SHINGRIX. The healthcare professional asked a general question over chat and reported that, he heard things like this but did not recall any specific details on the patients affected or the number of patients affected. No patient details were provided. This case has been linked with case US2018GSK159917, reported by same reporter.
Severe body aches, especially low back pain and neck pain; legs especially both knees felt very weak; fever 99+; bad chills; mild nausea; very tired; felt like I had flu ( but I received flu shot at end of September 2021. All these symptoms were on 10/26/2021. Wednesday 10/27/2021 felt 100%better; no symptoms except mild headache and mild low backache. Thursday 10/28/2021 at 3:00AM went to get up to go to BR and had extreme vertigo. Finally fell back to sleep and woke up at 9:45AM and had bad vertigo that continues today1029/2021. Called Dr 10/28/2021. Prescribed Meclizine 25 mg/ 1 tab every 6 hrs. After taking 3 doses as directed, was then seen by Dr On 10/29/2021.  Suggested I file reaction to site
faint, sweaty, nauseaous 116/78 60 BPM improved with fluids and reclining
This spontaneous report was received from a healthcare professional who reported that in January 2014, 21 improperly stored doses of ROTATEQ, (oral, dose, batch and lot number not reported) were administered by a clinic to an unspecified number of patients (age and gender were not reported). No adverse effects were reported. This is one of several reports from the same source. Follow up information has been received on 17-MAR-2014. All telephone attempts to obtain follow-up information had been unsuccessful. Follow up information has been received on 22-SEP-2014. Demographic details for each patient were provided. This report referred to a 12-year old female patient, who had no known drug allergies and no illness at time of vaccination. This report did not correspond to a patient vaccinated with ROTATEQ. Instead, the reporter informed that this patient was vaccinated with the first dose of GARDASIL (intramuscular injection, batch/lot # J008423, expiration date 21-JAN-2016, in the left arm, route not reported) on 24-FEB-2014 at 4:00 PM. It was reported that this dose was spoiled since the refrigerator was too cold (onset of event also reported as 27-FEB-2014 at 10:00 AM). The patient declined to repeat vaccine. No adverse event was reported for the patient. The outcome was reported by the reporter as unknown. This is one of several reports from the same source. Additional information is not expected since all follow ups requested to complete the case were received.
I did NOT have an adverse event from the vaccine or any of the boosters.  I was determined to have Covid from a pcr test on August 4, 2022.
Caller stated that he had his shot in the right arm and hour later he developed hives to the left side of his face. He took 50mg of Benadryl and the symptoms went away. He denies any other concerns at this time. Member informed to report the symptoms to website and follow up with his PCP or call back if he develops new symptoms.
ACUTE CORONARY SYNDROME, UNSPECIFIED 1/2/2022 NEAR SYNCOPE  ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 12/16/2021 NEAR SYNCOPE  ACUTE CORONARY SYNDROME, UNSPECIFIED 1/2/2022 COVID-19 PNEUMONIA  ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 12/16/2021 COVID-19 PNEUMONIA
I woke up in the morning and took a shower. I then noticed I had a rash on my neck, inch or inch and a half long. It didn't hurt. I went to the doctor thinking it may be Shingles. The doctor said it was most likely caused from the vaccine. No other symptoms. I took medication for 10 days and recovered. Had regular symptoms, flu like, after the COVID shot, but nothing out of the ordinary.
On the day after patient got the vaccine he experienced extreme fatigue and pain in the injection sites and body aches.
Sinuses felt congested/Feels like left side of head is congested; Left ear ache/inflammation; Momentary buzzing sound in left ear; Vertigo at night; Feeling foggy; Autoimmune fluid response (injection left arm); Left eye felt inflamed; Face felt swollen/fluid; This is a spontaneous report from a contactable consumer (patient).   A 58-year-old female patient received BNT162b2 (BNT162B2), dose 1, via an unspecified route of administration, administered in the left arm, on 30Mar2021 at 14:00 (Batch/Lot Number: 8733), at the age of 58 years old, as a single dose, for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient's medical history included asthma, Crohn's disease, and asymptomatic mild thrombocytopenia. The patient had allergy to penicillin, sulfa, preservatives, azithromycin (ZPACK), dust, mold, and sulfites; she also had seasonal allergies. Additionally, allergy to food included wheat, rye, oats, barley, quinoa, tomato, potato, celery, peas, banana, cantaloupe, strawberries, chocolate, tea, beef, and caffeine. In 1982 the patient reacted to an unspecified allergy shot with anaphylaxis and 4-day delayed reaction of serum sickness including liver dysfunction, swelling, rash, nausea, not being able to keep food or liquid down, treated with hydroxyzine (ATRAX) (started at day 5 of serum sickness which helped clear it up). The patient had not had COVID-19 prior to vaccination withy BNT162b2. Concomitant medications included mesalazine (LIALDA), cetirizine hydrochloride (ZYRTEC), mometasone furoate (ASMANEX), fluticasone propionate (FLONASE), and vitamin D. The patient had not received any other vaccines during the 4 weeks prior to BNT162b2 administration. The patient stated that 20 minutes after vaccination her left eye felt inflamed and 3 hours after vaccination her face felt swollen/fluid. The patient stated waking-up on 04Apr2021 at 06:00 AM with momentary buzzing sound in the left ear, ear ache/inflammation, sinuses feeling congested, lightheaded/dizziness all day, vertigo at night and on the following morning when lying on the left side, and feeling dizzy/lightheaded for 3 more days. The patient also reported feeling foggy, feeling like her left side of head was congested, and autoimmune fluid response (injection left arm) (as reported), all on 04Apr2021. Due to the events, the patient consulted a doctor or other healthcare professional office/clinic visit. No treatment was required for the events. The patient was not tested for COVID-19 after vaccination. The patient was recovering from all reported events with the exception of buzzing year which resolved on 04Apr2021.
Itching; soreness; headache; This spontaneous case was reported by a health care professional and describes the occurrence of PRURITUS (Itching), MYALGIA (soreness) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Nov-2021, the patient experienced PRURITUS (Itching), MYALGIA (soreness) and HEADACHE (headache). At the time of the report, PRURITUS (Itching), MYALGIA (soreness) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was provided.
TOOK TWO DIFFERENT COVID 19 VACCINES; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously treated with covid-19 vaccine for prophylactic vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 20-JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced took two different covid 19 vaccines. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of took two different covid 19 vaccines was not reported. This report was non-serious.
Later in the evening, I experienced a slight pressure in my chest and became "winded" or had shortness of breath like I had just climbed stairs.  I also had an aching pain across my upper / middle back.  This lasted for a few hours and then gradually I felt better.  This is exactly what happened after my first shot-  (Ref. VAERS ID #1186241,  E-Report #421989, filed on 04/09/2021)  except this time I have experienced an elevated heart rate and it has not yet gone back to my "normal".  That is why I have made this second report.
Grand mal seizure, or clonic-tonic seizure, First seizure.  Second clonic-tonic seizure occurred on 4/25/2017. Medication prescribed for seizures.
This case was reported by a consumer via call center representative and described the occurrence of headache in a female patient who received SHINGRIX for prophylaxis. On 31st July 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced headache, fever and shivering. On an unknown date, the outcome of the headache, fever and shivering were recovered/resolved. The reporter considered the headache, fever and shivering to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient reported that after a dose of SHINGRIX she experienced headache, shivering and fever for about 3 days. She was wondering if she would experience this again with the 2nd dose. The reporter did not give permission to contact her physician. The reporter did not consent to follow up.
Pt is a 38-year-old male who is seen in consultation for Dr. for evaluation of left arm lesion. Patient states he received a hepatitis A vaccine injection in his left arm on 10/8/18. Patient states that 3 weeks after the injection, he began having fevers twice a week ranging from 99-101°F. Patient states he noticed a hard area on his left upper extremity at the site of the injection. States this area has been increasing in size. Rates pain of left upper extremity at injection site 4/10. States the pain is worse when he raises his arm. Denies redness or drainage. Patient had ultrasound on 1/4/19 which revealed the following: Scanning of the left upper arm where the patient complains of a palpable abnormality reveals a somewhat poorly defined hypoechoic subcutaneous lesion measuring 9 x 3 mm suspicious for developing abscess; there is increased blood flow at the periphery of this abnormality; this is in the subcutaneous fat, superficial to the musculature. Laboratory studies on 1/4/19 reveal CMP within normal limits except for total protein elevated at 8.3, CBC within normal limits except for hematocrit low at 38.4. I&D Left arm. Wet-to-dry dressing BID. Cultures obtained.